Enterprise League logo

Product

MammaPrint

BIOTECHNOLOGY

byAgendia

United States (US)

ABOUT THE PRODUCT

The MammaPrint test is a 70-gene breast cancer recurrence assay that provides a risk of recurrence score. It is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines.

Information is owner-confirmed

Last updated 5 days ago

Price range
N/A

Other products/services from Agendia